Abstract
The use of the combination of a gestagen, medroxy‐progesterone acetate, and an androgen, testosterone enantate as a method for male contraception has been tried. The treatment was given at monthly injections, the gestagen at two dose levels. 150 and 300 mg/month and the androgen at 250 mg month. No substantial difference was observed between the two treatment schedules. Azoospermia was achieved in a majority of the patients within 4 months of treatment, but was never observed in all patients. After discontinuation the sperm count increased gradually after 2–3 months. This treatment schedule is not adequate for contraceptive purposes. Sexual impotency was not a problem for any of the subjects although testosterone in serum was reduced to 20–25% of the pretreatment level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
